In the wake of escalating costs of second-line HIV-AIDS drugs, Thailand has allowed, for the first time, the manufacture of the cost effective version of the drug 'Efavirenz', which has been a boon to many sufferers.
Merck & Co Inc, the patent holder of the drug has opposed the decision of the government to issue a five year license, allowing the manufacture and import of the drug, also termed, Stocrin. But this move has been seconded by AIDS activists and health experts.
Advertisement"This is both a brave and a progressive step by the Royal Thai Government to place the interests of people living with HIV in Thailand front and centre," UNAIDS country coordinator Patrick Brenny said
You May Also Like